毛喉鞘蕊花萃取物市场规模、份额及成长分析（依功效、应用、最终用户及地区划分）－2026-2033年产业预测

预计到 2024 年，毛喉鞘蕊花萃取物市场规模将达到 5.6396 亿美元，到 2025 年将成长至 6.2205 亿美元，到 2033 年将成长至 13.6279 亿美元，在预测期（2026-2033 年）年增长率为 10.3%。

毛喉素因其能够提高环磷酸腺苷（cAMP）水平，从而影响新陈代谢和发炎反应，而获得了市场关注。这促使它被推广为减肥补充剂，并治疗方法包括气喘、湿疹和干癣在内的多种健康问题。随着全球消费者越来越倾向于天然草药产品，毛喉素的需求也不断增长。在医药、化妆品和食品领域，消费者越来越青睐传统治疗方法而非合成替代品。北美，尤其是美国，由于对肥胖相关健康问题的日益关注以及对天然补充剂接受度的不断提高，正在推动毛喉素市场的发展。在亚太地区，深厚的印度传统医学底蕴也推动了类似的趋势，凸显了这种草药在多种健康应用中的重要作用，以及其在改善身体组成和治疗呼吸系统疾病方面的潜在益处。

毛喉鞘蕊花素市场驱动因素

推动毛喉鞘蕊花素市场发展的关键因素之一是消费者对天然保健品和保健产品的日益青睐。毛喉鞘蕊花素提取自毛喉鞘蕊花（Coleus forskohlii）的根部，在传统医学中有着悠久的应用历史，用于治疗多种健康问题。随着消费者对天然保健品益处的认识不断提高，以及对合成药物潜在副作用的日益关注，毛喉鞘蕊花素补充剂的需求持续增长。此外，肥胖症和心血管疾病等慢性疾病发生率的上升也进一步推动了对毛喉鞘蕊花素的需求，毛喉鞘蕊花素被认为是一种安全有效的应对这​​些健康挑战的手段。

限制毛喉鞘蕊花素市场的因素

毛喉鞘蕊花萃取物市场的一大挑战是产品生产和分销流程缺乏监管和标准化。消费者对天然保健品的需求不断增长，导致市场上充斥着大量毛喉鞘蕊花萃取物产品，其中许多产品可能不符合基本的品质和安全标准。这使得消费者面临购买无效甚至有害健康产品的风险。此外，法律规范的缺失导致产品效力和纯度参差不齐，进而造成使用者疗效不稳定。

毛喉鞘蕊花素市场趋势

随着消费者越来越重视健康和保健，毛喉鞘蕊花萃取物市场呈现出一个显着的趋势：对天然草本疗法的需求不断增长。这一转变反映了人们越来越倾向于选择合成药物的替代品，而毛喉鞘蕊花提取物因其草药特性和据称的健康益处而备受青睐。肥胖症和糖尿病等文明病发病率的上升也进一步推动了人们对天然疗法的兴趣。此外，越来越多的新参与企业加剧了市场竞争，刺激了创新，并促使开发出多样化、前沿的产品，以满足注重健康的消费者不断变化的偏好。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术进步

全球毛喉鞘蕊花萃取物市场规模（按强度和复合年增长率划分）（2026-2033 年）

• 低浓度（10%）
• 中等浓度（20%至40%）
• 高浓度（95%）

全球毛喉鞘蕊花素市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

• 过敏治疗
• 体重管理
• 呼吸系统疾病
• 心血管疾病
• 青光眼
• 甲状腺机能低下症
• 银屑病
• 其他的

全球毛喉鞘蕊花萃取物市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 保健品
• 製药
• 营养补充品
• 其他的

全球毛喉鞘蕊花萃取物市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Alchem International Ltd.（India）
• Nutra Green Biotechnology Co., Ltd.（China）
• Shaanxi Jiahe Phytochem Co., Ltd.（China）
• Glentham Life Sciences（United Kingdom）
• Flavour Trove（India）
• Cymbio Pharma Pvt. Ltd.（India）
• Alpspure Lifesciences Pvt. Ltd.（India）
• Bioprex Labs（India）
• Deccan Nutraceuticals Pvt. Ltd.（India）
• Ennature Biopharma（India）
• Sunpure Extracts Pvt. Ltd.（India）
• Sabinsa Corporation（United States）
• Indena SpA（Italy）
• ChromaDex Corp.（United States）
• Herbal Nutrition LLC（United States）
• Himalaya Wellness（India）
• Life Extension（United States）
• Nature's Way Products, LLC（United States）
• Swanson Health Products, Inc.（United States）
• NOW Foods（United States）

结论与建议

Forskolin Market size was valued at USD 563.96 Million in 2024 and is poised to grow from USD 622.05 Million in 2025 to USD 1362.79 Million by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

Forskolin is gaining traction in the market for its potential to boost cyclic AMP levels, influencing metabolism and inflammation. This has led to its promotion as a weight loss supplement and a treatment for various health issues, including asthma, eczema, and psoriasis. Demand for forskolin is rising amidst a global shift towards natural and herbal products, as consumers increasingly favor traditional remedies over synthetic alternatives in pharmaceuticals, cosmetics, and food. North America, particularly the United States, dominates the forskolin market due to the growing aversion to obesity-related health concerns and greater acceptance of natural supplements. In APAC, India's strong traditional medicine backdrop fuels similar trends, highlighting the herb's integral role across diverse health applications and its potential to enhance body composition and treat respiratory ailments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Forskolin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Forskolin Market Segments Analysis

Global Forskolin Market is segmented by Concentration, Application, End-User and region. Based on Concentration, the market is segmented into Low Concentration (10%), Medium Concentration (20%-40%) and High Concentration (95%). Based on Application, the market is segmented into Allergy Treatment, Weight Management, Respiratory Problems, Cardiovascular Disorders, Glaucoma, Hypothyroidism, Psoriasis and Others. Based on End-User, the market is segmented into Nutraceuticals, Pharmaceuticals, Dietary Supplements and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Forskolin Market

A significant factor propelling the Forskolin market is the escalating inclination towards natural supplements and wellness products. Forskolin, extracted from the root of the Coleus forskohlii plant, has a long-standing history in traditional medicine for addressing various health issues. As consumers become more aware of the advantages associated with natural supplements and grow apprehensive about the potential side effects of synthetic medications, the interest in Forskolin supplements continues to rise. Additionally, the increasing incidence of chronic health conditions like obesity and cardiovascular diseases has further fueled the demand for Forskolin, as it is perceived as a safe and effective means of managing these health challenges.

Restraints in the Forskolin Market

A significant challenge facing the Forskolin market is the absence of regulation and standardization in the manufacturing and distribution processes of Forskolin products. As demand for natural health supplements rises, the market has seen an influx of Forskolin offerings, many of which may not adhere to essential quality and safety standards. This situation exposes consumers to the risk of acquiring products that could be ineffective or, worse, detrimental to their health. Furthermore, the lack of regulatory oversight contributes to discrepancies in the potency and purity of these products, ultimately leading to inconsistent therapeutic benefits for users.

Market Trends of the Forskolin Market

The forskolin market is experiencing a notable trend towards the rising demand for natural and herbal remedies as consumers increasingly prioritize health and wellness. This shift reflects a broader movement towards seeking alternatives to synthetic pharmaceuticals, with forskolin gaining traction due to its herbal origins and purported health benefits. The escalating incidence of lifestyle-related diseases, such as obesity and diabetes, is further propelling interest in natural solutions. Additionally, the influx of new market entrants is heightening competition, fostering innovation, and resulting in the development of diverse, cutting-edge products that cater to the evolving preferences of health-conscious consumers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Forskolin Market Size by Concentration & CAGR (2026-2033)

• Market Overview
• Low Concentration (10%)
• Medium Concentration (20%-40%)
• High Concentration (95%)

Global Forskolin Market Size by Application & CAGR (2026-2033)

• Market Overview
• Allergy Treatment
• Weight Management
• Respiratory Problems
• Cardiovascular Disorders
• Glaucoma
• Hypothyroidism
• Psoriasis
• Others

Global Forskolin Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Nutraceuticals
• Pharmaceuticals
• Dietary Supplements
• Others

Global Forskolin Market Size & CAGR (2026-2033)

• North America (Concentration, Application, End-User)
  • US
  • Canada
• Europe (Concentration, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Concentration, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Concentration, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Concentration, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Alchem International Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutra Green Biotechnology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shaanxi Jiahe Phytochem Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glentham Life Sciences (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flavour Trove (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cymbio Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alpspure Lifesciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioprex Labs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deccan Nutraceuticals Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ennature Biopharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sunpure Extracts Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sabinsa Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indena S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChromaDex Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbal Nutrition LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himalaya Wellness (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Life Extension (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nature's Way Products, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swanson Health Products, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOW Foods (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations